Author

Bianca L Gonda

Harvard University

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:scRNA-seq· 1 Assay:spatial transcriptomics· 1

Frequent Co-Authors

Adam von Paternos· 1 shared Annie LiiD· 1 shared Anthony John IafrateiD· 1 shared Atul K. Bhan· 1 shared Chengzhuo GaoiD· 1 shared Daniel L. FadeniD· 1 shared Dawn R. MitchelliD· 1 shared Diane YangiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Adam von Paternos

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Reversible Downregulation of HLA Class I in Adenoid Cystic Carcinoma

Annie Li, Bianca L Gonda, Elizabeth M. Codd, Adam von Paternos, Dawn R. Mitchell, Markus D. Herrmann, Prinjali Kalyan, Samantha E. Flynn, Thuc Q Dzu, Chengzhuo Gao, Edwin Zhang, Julia J Mendel, Julia C Thierauf, Peter M. Sadow, Thomas Denize, , Anthony John Iafrate

This study identifies low HLA/B2M class I expression in ACC tumors and shows it can be reversed by interferon-ψ or STING agonists, suggesting a path for immunotherapy.

Journal for ImmunoTherapy of Cancer · Apr 1, 2025Peer-reviewedCancer Biology